Gerhard-Rüdiger Burmester

78PUBLICATIONS
315CO-AUTHORS
Fish physiology and geneticsMolecular targetsAutoimmunityRheumatology and arthritisMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (78)

|Jul 31, 2026
Filgotinib in Moderate to Severe Rheumatoid Arthritis in a Real-World Setting: Up to 6-Month Effectiveness, Patient-Reported Outcomes, and Persistence, and up to 24-Month Safety from More than 1400 Patients in the FILOSOPHY and PARROTFISH Studies.

|Jan 12, 2026
Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA).

Georg Pongratz, Rieke Alten, Torsten Witte

|Sep 01, 2025
To optimise the diagnostic process of rheumatic diseases affecting the hands using fluorescence optical imaging (FOI).

Nele Stumper, Jörn Berger, Jens Klotsche

|Aug 28, 2025
Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease.

Gerd R Burmester, Atul Deodhar, Alan D Irvine

|Aug 28, 2025
Medical Expert Knowledge Meets AI to Enhance Symptom Checker Performance for Rare Disease Identification in Fabry Disease: Mixed Methods Study.

Anne Pankow, Nico Meißner-Bendzko, Jessica Kaufeld

|Jun 03, 2025
Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular disease.

Pageof 13

Frequent Collaborators

9 joint publications

Kevin Winthrop

7 joint publications

Désirée van der Heijde

7 joint publications

Tanja A Stamm

7 joint publications

Daniel Aletaha